Prasugrel (Effient) vs. clopidogrel (Plavix)

Medical Letter on Drugs and Therapeutics

Volumn 51, Issue 1320, 2009, Pages 69-70

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EFFIENT; NONSTEROID ANTIINFLAMMATORY AGENT; PRASUGREL; UNCLASSIFIED DRUG; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; PIPERAZINE DERIVATIVE; THIOPHENE DERIVATIVE; TICLOPIDINE;

ACUTE CORONARY SYNDROME; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG COST; DRUG EFFICACY; DRUG EXCRETION; DRUG FORMULATION; DRUG METABOLISM; DRUG WITHDRAWAL; HALF LIFE TIME; HEART DEATH; HEART INFARCTION; HUMAN; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; RECOMMENDED DRUG DOSE; SHORT SURVEY; ST SEGMENT ELEVATION; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; ANIMAL; DRUG APPROVAL; ECONOMICS; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; UNITED STATES;

ANIMALS; DRUG APPROVAL; HUMANS; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THIOPHENES; TICLOPIDINE; UNITED STATES;

EID: 70349576351     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. DL Bhatt. Prasugrel in clinical practice. N Engl J Med 2009 July 15 epub.
2. Antiplatelet and anticoagulant drugs. Treat Guidel Med Lett 2008; 6:29.
3. Antiplatelet therapy for patients with stents. Med Lett Drugs Ther 2008; 50:61.
4. PPI interactions with clopidogrel revisited. Med Lett Drugs Ther 2009; 51:13.
5. JL Mega et al. Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 2009; 119:2553.
6. SD Wiviott et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357:2001.
7. DL Bhatt. Intensifying platelet inhibition - navigating between Scylla and Charybdis. N Engl J Med 2007; 357:2078.
8. G Montalescot et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009; 373:723.